Prognostic value of AR mutation in primary African American prostate cancer

AR 突变在非裔美国人原发性前列腺癌中的预后价值

• 批准号: 7989304
• 负责人: SHAHRIAR KOOCHEKPOUR
• 金额: $ 19.98万
• 依托单位: LSU HEALTH SCIENCES CENTER
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7989304
• 关键词: Address; African American; Age; American; Androgen Receptor; Androgens; Benign; Biochemical; Cancer Patient; Cancer-Predisposing Gene; Caucasians; Caucasoid Race; Cell Line; Cells; Clinical; DNA; DNA Binding Domain; Data; Diagnostic Neoplasm Staging; Disease; Epidemiologist; Event; Exons; Family history of; Flow Cytometry; Frequencies; Gene Mutation; Gene Targeting; Genomics; Germ-Line Mutation; Gleason Grade for Prostate Cancer; Heterogeneity; Hormones; Incidence; Individual; Knowledge; Laboratories; Lasers; Lead; Malignant - descriptor; Malignant neoplasm of prostate; Molecular; Mutate; Mutation; Natural History; Outcome; PC3 cell line; Paraffin Embedding; Pathological Staging; Pathologist; Patients; Pattern; Prevalence; Prognostic Factor; Prognostic Marker; Prostate; Prostate-Specific Antigen; Radical Prostatectomy; Receptor Gene; Recurrence; Refractory; Refractory Disease; Reporting; Sampling; Somatic Mutation; Specimen; Staging; Staining method; Stains; Testing; Therapeutic; Therapeutic Intervention; Tissue Banking; Tissue Banks; Tissues; Tumor Volume; Tumor stage; cancer site; caucasian American; density; laser capture microdissection; men; mortality; novel; prognostic; prostate carcinogenesis; protein expression; public health relevance; receptor; receptor density; receptor expression; receptor-mediated signaling; tissue resource; tumor; tumor progression

DESCRIPTION (provided by applicant): Prostate cancer (PCa) incidence and mortality rate is higher in African American (AA) men than in Caucasian Americans (CAs). AA men with PCa also present with higher tumor volume, more advanced tumor stage, and higher Gleason grade. Prostate carcinogenesis and tumor progression are related strongly to the expression and activity of the androgen receptor (AR). Mutations and genomic amplification of AR also can increase AR expression and/or activity. In CAs, AR mutations are infrequent (<1%) in localized tumors, but occur at a higher frequency in advanced, metastatic, or hormone-refractory disease. In AAs, the prevalence of AR mutations and their prognostic significances in primary PCa are unknown. We discovered genomic amplification and somatic mutation of AR in a PCa cell line established by our laboratory from an AA patient with localized PCa. We analyzed a set of 91 radical prostatectomy samples (57 AAs and 34 CAs) in which we identified 8 AR mutations (7 somatic and 1 germline) in AA patients, but found no mutations in CA patients. These data led us to hypothesize that AR mutations in primary African Americans PCa is more frequent than expected and may contribute to disease aggressiveness or serve as a prognostic factor. Our Specific Aims are: Aim 1: Determine the prevalence of AR mutations in primary African Americans PCa. Exon-specific primers of the AR gene will be used to sequence genomic-DNA extracted from laser-captured cells of paraffin- embedded tissue sections of radical prostatectomy specimens in order to determine the prevalence of somatic AR mutations in 400 AA patients with primary untreated PCa, and compare this frequency of mutation with that observed in 100 equivalent CA patients. Aim 2: Determine the contribution of AR mutation to PCa heterogeneity in African Americans. Clinical and histopathological heterogeneity of PCa present a major challenge to therapeutic interventions. Differences in AR expression and microvascular density are considered as the two major contributors to PCa heterogeneity. We will use flow cytometry and immunohistochemical staining to examine AR and microvessel density in AA PCa with mutated AR. Aim 3: Define the prognostic significance of AR mutations in primary African American PCa. We will determine the prognostic significance of AR mutations alone or in combination with AR density or microvessel density in relation to clinical or histopathological variables including age, PSA, Gleason score, pathological stage, biochemical recurrence, and family history, with a focus on Gleason sum or pattern as a central prognostic marker. Significance: The results of this exploratory project will provide new knowledge about both the prevalence and prognostic value of AR mutations and may help us to understand better and address more effectively the potential racial disparity between PCa aggressiveness in AAs and CAs. PUBLIC HEALTH RELEVANCE: The incidences, mortality, and aggressiveness of prostate cancer (PCa) in African-American (AA) men are higher than in Caucasians. To understand and address the racial disparity of the disease aggressiveness, reliable prognostic factors are needed. Our discovery of a high frequency of androgen receptor mutations in untreated localized AA PCa might have prognostic significance that would provide us a more effective therapeutic approach.

描述(申请人提供)：非裔美国人(AA)男性的前列腺癌(PCA)发病率和死亡率高于白人美国人(CA)。患有前列腺癌的AA患者肿瘤体积更大，肿瘤分期更晚期，Gleason分级更高。前列腺癌的发生和发展与雄激素受体(AR)的表达和活性密切相关。AR的突变和基因组扩增也可以增加AR的表达和/或活性。在CA中，AR突变在局部肿瘤中很少见(1%)，但在晚期、转移性或激素难治性疾病中发生频率较高。在AAS中，AR突变在原发PCa中的流行及其预后意义尚不清楚。我们在实验室从1例局限性前列腺癌患者建立的前列腺癌细胞系中发现了AR的基因组扩增和体细胞突变。我们分析了91例前列腺癌根治术标本(57例AA和34例CA)，在AA患者中发现了8个AR突变(7个体细胞突变和1个生殖系突变)，但在CA患者中没有发现突变。这些数据使我们假设，原发的非裔美国人前列腺癌的AR突变比预期的更频繁，可能有助于疾病侵袭性或作为预后因素。我们的具体目标是：目标1：确定AR突变在原发非裔美国人前列腺癌中的流行率。我们将使用AR基因的外显子特异性引物对从根治性前列腺癌标本石蜡包埋组织切片的激光捕获细胞中提取的基因组DNA进行测序，以确定400例原发未经治疗的前列腺癌AA患者的体细胞AR突变的发生率，并将这一突变频率与100例同等的CA患者的突变频率进行比较。目的2：确定AR突变对非裔美国人前列腺癌异质性的贡献。PCa的临床和组织病理异质性是治疗干预的主要挑战。AR表达和微血管密度的差异被认为是导致PCa异质性的两个主要因素。我们将使用流式细胞术和免疫组织化学染色来检测AR突变的AA-PCa的AR和微血管密度。目的3：明确AR突变在原发非裔美国人前列腺癌中的预后意义。我们将确定AR突变单独或联合AR密度或微血管密度与临床或组织病理学变量的关系的预后意义，包括年龄、PSA、Gleason评分、病理分期、生化复发和家族史，重点关注Gleason总数或模式作为中心预后标志。意义：这一探索性项目的结果将为AR突变的患病率和预后价值提供新的知识，并可能帮助我们更好地理解和更有效地解决AAS和CA中PCa侵袭性之间的潜在种族差异。 公共卫生相关性：非裔美国人(AA)男性前列腺癌(PCA)的发病率、死亡率和侵袭性高于高加索人。要了解和解决疾病侵袭性的种族差异，需要可靠的预后因素。我们在未经治疗的局限性AA-PCa中发现了高频率的雄激素受体突变，这可能具有预后意义，将为我们提供一种更有效的治疗方法。